Pub Date : 2025-02-03eCollection Date: 2025-01-01DOI: 10.14744/nci.2023.66891
Ulas Hurdoganoglu, Nezihal Gokbulut, Emrah Guler, Kaya Suer, Evren Hincal
Objective: The purpose of this study is to analyze the situation of Methicillin-Resistant Staphylococcus aureus (MRSA) in TRNC by examining the prevalence of Community-acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA)/Hospital-acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) cases, the acceleration of CA-MRSA/HA-MRSA patients from past to present, the impact of pandemic, gender and age on MRSA cases.
Methods: In order to analyze the trend of MRSA cases and the effects of selected parameters on MRSA cases, statistical tests are employed to the obtained data including ANOVA test, regression analysis tests and Post-hoc Tukey test.
Results: Incidence rate of MRSA carriage in the community has increased over the years to 45.6%. p-value of the relationship between community-acquired MRSA cases and hospital-acquired MRSA cases is less than 0.05. The results also revealed that the p-value of both the relationship between COVID-19 and MRSA cases and the relationship between 50+ age and MRSA cases are significant. On the other hand, p-value of the relationship between gender and MRSA cases is found to be greater than 0.05.
Conclusion: It is concluded that MRSA carriage in the community has increased over the years and CA-MRSA and HA-MRSA cases are related since p<0.05. Moreover, it's revealed that there is an effect of COVID-19 pandemic and 50+ age (66% of the cases) on MRSA cases because of p<0.05 while the gender is not an effect for MRSA cases in the country, since p-value for gender comparison is greater than 0.05.
{"title":"Trend determination of methicillin-resistant <i>Staphylococcus aureus</i> infections with statistical modeling.","authors":"Ulas Hurdoganoglu, Nezihal Gokbulut, Emrah Guler, Kaya Suer, Evren Hincal","doi":"10.14744/nci.2023.66891","DOIUrl":"10.14744/nci.2023.66891","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study is to analyze the situation of Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) in TRNC by examining the prevalence of Community-acquired Methicillin-Resistant <i>Staphylococcus aureus</i> (CA-MRSA)/Hospital-acquired Methicillin-Resistant <i>Staphylococcus aureus</i> (HA-MRSA) cases, the acceleration of CA-MRSA/HA-MRSA patients from past to present, the impact of pandemic, gender and age on MRSA cases.</p><p><strong>Methods: </strong>In order to analyze the trend of MRSA cases and the effects of selected parameters on MRSA cases, statistical tests are employed to the obtained data including ANOVA test, regression analysis tests and Post-hoc Tukey test.</p><p><strong>Results: </strong>Incidence rate of MRSA carriage in the community has increased over the years to 45.6%. p-value of the relationship between community-acquired MRSA cases and hospital-acquired MRSA cases is less than 0.05. The results also revealed that the p-value of both the relationship between COVID-19 and MRSA cases and the relationship between 50+ age and MRSA cases are significant. On the other hand, p-value of the relationship between gender and MRSA cases is found to be greater than 0.05.</p><p><strong>Conclusion: </strong>It is concluded that MRSA carriage in the community has increased over the years and CA-MRSA and HA-MRSA cases are related since p<0.05. Moreover, it's revealed that there is an effect of COVID-19 pandemic and 50+ age (66% of the cases) on MRSA cases because of p<0.05 while the gender is not an effect for MRSA cases in the country, since p-value for gender comparison is greater than 0.05.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"12-20"},"PeriodicalIF":0.9,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-31eCollection Date: 2025-01-01DOI: 10.14744/nci.2024.69908
Hatice Ecem Konak, Serdar Can Guven, Ebru Atalar, Pinar Akyuz Dagli, Rezan Kocak Ulucakoy, Esra Kayacan Erdogan, Hakan Babaoglu, Berkan Armagan, Kevser Orhan, Ismail Dogan, Yuksel Maras, Ahmet Omma, Orhan Kucuksahin, Sukran Erten
Objective: The aim of this study is to determine the frequency and clinical features of diagnosed rheumatological disease in patients who have no previous history of rheumatic disease and are consulted to the rheumatology clinic from other departments to investigate the etiology of early-onset ischemic stroke.
Methods: Patients aged 18-65, who had not previously been diagnosed with rheumatic disease, had ischemic stroke for the first time, and were consulted to rheumatology clinic to investigate the etiology of the disease, were retrospectively included in the study. Demographics, clinic laboratory, imaging data and the final diagnosis of the patients were obtained from hospital records.
Results: A total of 115 patients who had their first ischemic stroke were identified in the study. 70 of them were detected to have young ischemic stroke. Of these patients, 1 was diagnosed with lupus with secondary antiphospholipid syndrome (APS) and Sjögren's syndrome 1 with lupus and secondary APS, 2 with primary APS, 1 with lupus, 1 with primary Sjögren's syndrome and 1 with granulomatous with polyangiitis.
Conclusion: Determining the correct etiological diagnosis of ischemic stroke, especially in young adults, is important in terms of preventing recurrent ischemic attacks. It is important to raise awareness of clinicians in terms of rheumatic diseases and to refer patients to the rheumatology department if deemed necessary.
{"title":"Rheumatic diseases presenting with young ischemic stroke: Revelations from tertiary center experience.","authors":"Hatice Ecem Konak, Serdar Can Guven, Ebru Atalar, Pinar Akyuz Dagli, Rezan Kocak Ulucakoy, Esra Kayacan Erdogan, Hakan Babaoglu, Berkan Armagan, Kevser Orhan, Ismail Dogan, Yuksel Maras, Ahmet Omma, Orhan Kucuksahin, Sukran Erten","doi":"10.14744/nci.2024.69908","DOIUrl":"10.14744/nci.2024.69908","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to determine the frequency and clinical features of diagnosed rheumatological disease in patients who have no previous history of rheumatic disease and are consulted to the rheumatology clinic from other departments to investigate the etiology of early-onset ischemic stroke.</p><p><strong>Methods: </strong>Patients aged 18-65, who had not previously been diagnosed with rheumatic disease, had ischemic stroke for the first time, and were consulted to rheumatology clinic to investigate the etiology of the disease, were retrospectively included in the study. Demographics, clinic laboratory, imaging data and the final diagnosis of the patients were obtained from hospital records.</p><p><strong>Results: </strong>A total of 115 patients who had their first ischemic stroke were identified in the study. 70 of them were detected to have young ischemic stroke. Of these patients, 1 was diagnosed with lupus with secondary antiphospholipid syndrome (APS) and Sjögren's syndrome 1 with lupus and secondary APS, 2 with primary APS, 1 with lupus, 1 with primary Sjögren's syndrome and 1 with granulomatous with polyangiitis.</p><p><strong>Conclusion: </strong>Determining the correct etiological diagnosis of ischemic stroke, especially in young adults, is important in terms of preventing recurrent ischemic attacks. It is important to raise awareness of clinicians in terms of rheumatic diseases and to refer patients to the rheumatology department if deemed necessary.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"103-110"},"PeriodicalIF":0.9,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364476/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-31eCollection Date: 2025-01-01DOI: 10.14744/nci.2024.25564
Hanife Nur Karakoc, Asli Haykir Solay, Tugba Arikan, Oguz Alp Gurbuz, Zubeyde Lale, Irfan Sencan
Objective: Urinary tract infections (UTIs) are among the most common bacterial infections. The misuse of antibiotics is one of the factors contributing to the global increase in antimicrobial resistance (AMR), making the management of UTIs more challenging. Our study aims to evaluate the causative agents of UTIs and the factors influencing resistance, as well as to identify antibiotics that can be used in the outpatient treatment of patients diagnosed with UTIs.
Methods: This retrospective study was conducted by collecting urine sample results between 2015-2023. The culture results of the urine samples and the results of the antibiotic sensitivity tests of the Enterobacteriaceae isolates were analyzed. Antimicrobial susceptibilities of the isolates were defined using the VITEK®2 Compact system (bioMérieux, Marcyl'Etoile, France) and PheonixTM (Becton-Dickinson, NJ, USA). All sensitivity statuses were determined according to EUCAST standards. Data analysis was conducted using SPSS software version 23.
Results: 1842 culture results were included. 71.5% of the included samples were from women, and the average age of the cases was 63±18. The most commonly grown agent in urine cultures is Escherichia coli. The resistance profile of the Enterobacteriaceae to antibacterial agents was examined, and it was found that the highest resistance rates were against ampicillin (77.92%), cefazolin (52.36%), ciprofloxacin (49.5%), and trimethoprim/sulfamethoxazole (45.5%), while the lowest resistance rates were against meropenem (4.9%), amikacin (7.6%), fosfomycin (11.4%), and nitrofurantoin (11.6%). Comparing resistance rates before and after 2019, a significant increase in resistance to amikacin and nitrofurantoin was observed (p≤0.001). It was found that resistance rates were higher in urine samples from male cases.
Conclusion: Our study revealed that patients should be carefully evaluated in terms of the necessity of culture requests and patients should be informed about culture requests due to the high rate of non-growth and contamination in urine culture results. The high rates of antimicrobial resistance were detected, and the outpatient treatment options of UTI patients are narrowing which can increase hospital admission rates. Our study is important because it shows that nitrofurantoin and fosfomycin can be included in the outpatient and empirical treatment of UTI patients.
{"title":"Comprehensive analysis of antibiotic resistance in Enterobacteriaceae from outpatient urine cultures: Implications for empirical therapy.","authors":"Hanife Nur Karakoc, Asli Haykir Solay, Tugba Arikan, Oguz Alp Gurbuz, Zubeyde Lale, Irfan Sencan","doi":"10.14744/nci.2024.25564","DOIUrl":"10.14744/nci.2024.25564","url":null,"abstract":"<p><strong>Objective: </strong>Urinary tract infections (UTIs) are among the most common bacterial infections. The misuse of antibiotics is one of the factors contributing to the global increase in antimicrobial resistance (AMR), making the management of UTIs more challenging. Our study aims to evaluate the causative agents of UTIs and the factors influencing resistance, as well as to identify antibiotics that can be used in the outpatient treatment of patients diagnosed with UTIs.</p><p><strong>Methods: </strong>This retrospective study was conducted by collecting urine sample results between 2015-2023. The culture results of the urine samples and the results of the antibiotic sensitivity tests of the Enterobacteriaceae isolates were analyzed. Antimicrobial susceptibilities of the isolates were defined using the VITEK<sup>®</sup>2 Compact system (bioMérieux, Marcyl'Etoile, France) and PheonixTM (Becton-Dickinson, NJ, USA). All sensitivity statuses were determined according to EUCAST standards. Data analysis was conducted using SPSS software version 23.</p><p><strong>Results: </strong>1842 culture results were included. 71.5% of the included samples were from women, and the average age of the cases was 63±18. The most commonly grown agent in urine cultures is Escherichia coli. The resistance profile of the Enterobacteriaceae to antibacterial agents was examined, and it was found that the highest resistance rates were against ampicillin (77.92%), cefazolin (52.36%), ciprofloxacin (49.5%), and trimethoprim/sulfamethoxazole (45.5%), while the lowest resistance rates were against meropenem (4.9%), amikacin (7.6%), fosfomycin (11.4%), and nitrofurantoin (11.6%). Comparing resistance rates before and after 2019, a significant increase in resistance to amikacin and nitrofurantoin was observed (p≤0.001). It was found that resistance rates were higher in urine samples from male cases.</p><p><strong>Conclusion: </strong>Our study revealed that patients should be carefully evaluated in terms of the necessity of culture requests and patients should be informed about culture requests due to the high rate of non-growth and contamination in urine culture results. The high rates of antimicrobial resistance were detected, and the outpatient treatment options of UTI patients are narrowing which can increase hospital admission rates. Our study is important because it shows that nitrofurantoin and fosfomycin can be included in the outpatient and empirical treatment of UTI patients.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"36-44"},"PeriodicalIF":0.9,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-30eCollection Date: 2025-01-01DOI: 10.14744/nci.2023.12316
Hakan Yazan
Objective: Flexible bronchoscopy (FB) is an important tool for evaluating pediatric patients with respiratory issues. This study aims to investigate the clinical features of children who underwent FB.
Methods: The study included 191 children who underwent FB between April 1, 2021 and December 31, 2022. Demographic and clinical data were retrospectively reviewed.
Results: One hundred ninety-one children (45% girl) were enrolled to study. Median age was 25 months (min 1, max 214 months) and median duration of complaints was 4 (min 1, max 80) months. Among the patients, 61.7% of them had a chronic disease. The main indications were stridor (17.6%) and extubation failure (13.5%). Rate of patients in the ICU during FB was 27.5% and 15.5% of them were intubated. Airway secretions in the lower respiratory tract and isolated laryngomalacia were the most common abnormal FB results (30.1% and 9.8% respectively). The most common abnormal FB findings were in children with extubation failure (92.3%). Forty percent of patients with chronic cough had abnormal FB findings. Bronchoalveolar lavage (BAL) sampling was performed in 61.6% (n=119) of patients and Haemophilus influenzae was the most common pathogen in these patients (n=40).
Conclusion: FB is a valuable tool for investigating airway pathology and BAL sampling in children with respiratory problems.
{"title":"Pediatric flexible bronchoscopy: A tertiary single center experience.","authors":"Hakan Yazan","doi":"10.14744/nci.2023.12316","DOIUrl":"10.14744/nci.2023.12316","url":null,"abstract":"<p><strong>Objective: </strong>Flexible bronchoscopy (FB) is an important tool for evaluating pediatric patients with respiratory issues. This study aims to investigate the clinical features of children who underwent FB.</p><p><strong>Methods: </strong>The study included 191 children who underwent FB between April 1, 2021 and December 31, 2022. Demographic and clinical data were retrospectively reviewed.</p><p><strong>Results: </strong>One hundred ninety-one children (45% girl) were enrolled to study. Median age was 25 months (min 1, max 214 months) and median duration of complaints was 4 (min 1, max 80) months. Among the patients, 61.7% of them had a chronic disease. The main indications were stridor (17.6%) and extubation failure (13.5%). Rate of patients in the ICU during FB was 27.5% and 15.5% of them were intubated. Airway secretions in the lower respiratory tract and isolated laryngomalacia were the most common abnormal FB results (30.1% and 9.8% respectively). The most common abnormal FB findings were in children with extubation failure (92.3%). Forty percent of patients with chronic cough had abnormal FB findings. Bronchoalveolar lavage (BAL) sampling was performed in 61.6% (n=119) of patients and Haemophilus influenzae was the most common pathogen in these patients (n=40).</p><p><strong>Conclusion: </strong>FB is a valuable tool for investigating airway pathology and BAL sampling in children with respiratory problems.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"83-88"},"PeriodicalIF":0.9,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-30eCollection Date: 2025-01-01DOI: 10.14744/nci.2024.34033
Gunay Rona, Neriman Fistikcioglu, Tekin Ahmet Serel, Meral Arifoglu, Mehmet Bilgin Eser, Serhat Ozcelik, Kadriye Aydin
Objective: This study aims to explore the predictive performance of machine learning-based radiomic features extracted from T2-weighted magnetic resonance imaging (MRI) in differentiating between women with polycystic ovary syndrome (PCOS) and healthy counterparts.
Methods: The study included patients diagnosed with PCOS who had undergone pelvic MRI in the endocrine department between 2014 and 2022, along with an age-matched control group. The ovaries were manually segmented from T2-weighted images using the 3D Slicer software. Both first- and second-order features, including wavelet filters, were extracted from the images. Utilizing the Python 2.3 programming language and the Pycaret library, various machine learning algorithms were employed to identify highly correlated features. The optimal model was selected from the 15 algorithms assessed.
Results: The study involved a total of 202 ovaries from 101 patients with PCOS (mean age 23±4 years) and 78 ovaries from the control group comprising 40 individuals (mean age 24±5 years). In the training set, the machine learning models displayed accuracy and area under the curve (AUC) values ranging from 72% to 83% and 0.50 to 0.81%, respectively. Notably, the Light Gradient Boosting Machine (LightGBM) model emerged as the most effective model among the various machine learning algorithms, exhibiting an AUC of 0.81 and an accuracy of 83%. When evaluated on the test set, the AUC, accuracy, recall, precision and F1 values of the LightGBM model were 0.80, 82%, 91%, 86%, 88%, respectively.
Conclusion: Machine learning-based T2-weighted MRI radiomics seems viable in differentiating between individuals with and without PCOS.
目的:本研究旨在探讨基于机器学习的t2加权磁共振成像(MRI)放射学特征在多囊卵巢综合征(PCOS)女性与健康女性鉴别中的预测性能。方法:研究纳入2014年至2022年间在内分泌科接受盆腔MRI诊断为PCOS的患者,以及年龄匹配的对照组。使用3D Slicer软件从t2加权图像中手动分割卵巢。从图像中提取一阶和二阶特征,包括小波滤波器。利用Python 2.3编程语言和Pycaret库,采用各种机器学习算法来识别高度相关的特征。从评估的15种算法中选择最优模型。结果:本研究共纳入101例PCOS患者(平均年龄23±4岁)的202个卵巢和40例对照组(平均年龄24±5岁)的78个卵巢。在训练集中,机器学习模型的准确率和曲线下面积(area under the curve, AUC)值分别为72% ~ 83%和0.50 ~ 0.81%。值得注意的是,光梯度增强机(Light Gradient Boosting Machine, LightGBM)模型是各种机器学习算法中最有效的模型,AUC为0.81,准确率为83%。在测试集上评估时,LightGBM模型的AUC、准确率、召回率、精密度和F1值分别为0.80、82%、91%、86%、88%。结论:基于机器学习的t2加权MRI放射组学似乎可以区分PCOS患者和非PCOS患者。
{"title":"Predictive value of machine learning-based T2-weighted MRI radiomics in the diagnosis of polycystic ovary syndrome.","authors":"Gunay Rona, Neriman Fistikcioglu, Tekin Ahmet Serel, Meral Arifoglu, Mehmet Bilgin Eser, Serhat Ozcelik, Kadriye Aydin","doi":"10.14744/nci.2024.34033","DOIUrl":"10.14744/nci.2024.34033","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to explore the predictive performance of machine learning-based radiomic features extracted from T2-weighted magnetic resonance imaging (MRI) in differentiating between women with polycystic ovary syndrome (PCOS) and healthy counterparts.</p><p><strong>Methods: </strong>The study included patients diagnosed with PCOS who had undergone pelvic MRI in the endocrine department between 2014 and 2022, along with an age-matched control group. The ovaries were manually segmented from T2-weighted images using the 3D Slicer software. Both first- and second-order features, including wavelet filters, were extracted from the images. Utilizing the Python 2.3 programming language and the Pycaret library, various machine learning algorithms were employed to identify highly correlated features. The optimal model was selected from the 15 algorithms assessed.</p><p><strong>Results: </strong>The study involved a total of 202 ovaries from 101 patients with PCOS (mean age 23±4 years) and 78 ovaries from the control group comprising 40 individuals (mean age 24±5 years). In the training set, the machine learning models displayed accuracy and area under the curve (AUC) values ranging from 72% to 83% and 0.50 to 0.81%, respectively. Notably, the Light Gradient Boosting Machine (LightGBM) model emerged as the most effective model among the various machine learning algorithms, exhibiting an AUC of 0.81 and an accuracy of 83%. When evaluated on the test set, the AUC, accuracy, recall, precision and F1 values of the LightGBM model were 0.80, 82%, 91%, 86%, 88%, respectively.</p><p><strong>Conclusion: </strong>Machine learning-based T2-weighted MRI radiomics seems viable in differentiating between individuals with and without PCOS.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"69-75"},"PeriodicalIF":0.9,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Lung cancer is one of the most prevalent malignancies worldwide, with 80-85% of cases diagnosed as non-small cell lung cancer (NSCLC). The majority of NSCLC patients present with advanced disease, contributing to high mortality and limited treatment options. Angiogenesis, a crucial process in cancer progression, is largely regulated by growth factors and cytokines. Vascular Endothelial Growth Factor (VEGF) is a key regulator of angiogenesis. Asymmetric Dimethyl Arginine (ADMA) inhibits endothelial nitric oxide synthase (eNOS), leading to reduced nitric oxide (NO) release and subsequent endothelial dysfunction. The aim of this study is to investigate the serum levels of ADMA, NO, VEGF and several tumor markers including Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA 125), Neuron Specific Enolase (NSE), Lactate dehydrogenase (LDH) and Cyfra 21-1 in NSCLC patients to assess their potential role in early diagnosis, tumor invasion, and staging of the disease.
Methods: Our study consisted of 56 newly diagnosed NSCLC patients and 32 controls with similar demographic characteristics. Patients with chronic diseases and inflammatory disorders were excluded. Statistical analysis was conducted using R Statistical Software.
Results: In our study, compared to the control group, the serum VEGF, NO, ADMA, CA 125, CEA, Cyfra 21-1 and NSE levels were significantly higher in NSCLC group (p=0.001, p=0.013, p=0.041, p<0.001, p<0.001, p<0.001 and p=0.001, respectively). In the diagnosis of NSCLC, Cyfra 21-1 exhibited the highest diagnostic efficacy with a 71% sensitivity and 94% specificity. The combination of VEGF, CA125, and Cyfra 21-1 showed a 73% sensitivity and 100% specificity, while the combination of CA125, CEA, and Cyfra 21-1 achieved an 85% sensitivity and 91% specificity.
Conclusion: Our study revealed that the serum concentrations of VEGF, NO, ADMA, CA125, Cyfra 21-1, CEA, and NSE were significantly elevated in patients with NSCLC compared to the control group, and that levels of Cyfra 21-1, LDH, and NSE increased with advancing TNM stage. The combination of markers distinguished NSCLC with high sensitivity and specificity. Further studies involving larger populations, including those with benign lung diseases, are needed to validate and expand upon our findings.
{"title":"Assessment of serum vascular endothelial growth factor, nitric oxide and asymmetric dimethyl arginine levels in non-small cell lung cancer.","authors":"Esra Paydas Hataysal, Fikret Kanat, Muslu Kazim Korez, Farise Yilmaz, Ali Unlu, Husamettin Vatansev","doi":"10.14744/nci.2024.38991","DOIUrl":"10.14744/nci.2024.38991","url":null,"abstract":"<p><strong>Objective: </strong>Lung cancer is one of the most prevalent malignancies worldwide, with 80-85% of cases diagnosed as non-small cell lung cancer (NSCLC). The majority of NSCLC patients present with advanced disease, contributing to high mortality and limited treatment options. Angiogenesis, a crucial process in cancer progression, is largely regulated by growth factors and cytokines. Vascular Endothelial Growth Factor (VEGF) is a key regulator of angiogenesis. Asymmetric Dimethyl Arginine (ADMA) inhibits endothelial nitric oxide synthase (eNOS), leading to reduced nitric oxide (NO) release and subsequent endothelial dysfunction. The aim of this study is to investigate the serum levels of ADMA, NO, VEGF and several tumor markers including Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA 125), Neuron Specific Enolase (NSE), Lactate dehydrogenase (LDH) and Cyfra 21-1 in NSCLC patients to assess their potential role in early diagnosis, tumor invasion, and staging of the disease.</p><p><strong>Methods: </strong>Our study consisted of 56 newly diagnosed NSCLC patients and 32 controls with similar demographic characteristics. Patients with chronic diseases and inflammatory disorders were excluded. Statistical analysis was conducted using R Statistical Software.</p><p><strong>Results: </strong>In our study, compared to the control group, the serum VEGF, NO, ADMA, CA 125, CEA, Cyfra 21-1 and NSE levels were significantly higher in NSCLC group (p=0.001, p=0.013, p=0.041, p<0.001, p<0.001, p<0.001 and p=0.001, respectively). In the diagnosis of NSCLC, Cyfra 21-1 exhibited the highest diagnostic efficacy with a 71% sensitivity and 94% specificity. The combination of VEGF, CA125, and Cyfra 21-1 showed a 73% sensitivity and 100% specificity, while the combination of CA125, CEA, and Cyfra 21-1 achieved an 85% sensitivity and 91% specificity.</p><p><strong>Conclusion: </strong>Our study revealed that the serum concentrations of VEGF, NO, ADMA, CA125, Cyfra 21-1, CEA, and NSE were significantly elevated in patients with NSCLC compared to the control group, and that levels of Cyfra 21-1, LDH, and NSE increased with advancing TNM stage. The combination of markers distinguished NSCLC with high sensitivity and specificity. Further studies involving larger populations, including those with benign lung diseases, are needed to validate and expand upon our findings.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"45-54"},"PeriodicalIF":0.9,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Cardiovascular disease (CVD) is the most common cause of death in chronic kidney disease (CKD) patients. The prevalence of CVD is significantly increased in CKD patients, and the frequency of CVD increases as the CKD stage worsens. Although atherosclerosis is more common in CKD patients, the lipid profile may change as the CKD stage changes. Many mechanisms cause this. Also, mortality is more common in patients with advanced CKD. In this study, we aim to emphasize the incidence of cardiovascular diseases and dyslipidemia in patients with CKD at different stages and the effect of these variable conditions on patient mortality.
Methods: Patients who applied to the internal medicine outpatient clinic and were diagnosed with chronic kidney disease were examined. Mortality and complications were followed up for one year. A total of 1323 patients with a diagnosis of CKD between stages 3a-5 were included in the study. The relationships between kidney functions and lipid profiles, biochemical values, and prognosis of the patients were evaluated.
Results: Non-survivors had lower glomerular filtration rate (GFR) and higher C-reactive protein (CRP) levels. High-density lipoprotein (HDL), low-density lipoprotein (LDL), and albumin values decreased, and CRP increased as the disease stage progressed. More survivors had CKD and hyperlipidemia than non-survivors. It was observed that the stage remained the same in patients with hyperlipidemia at a higher rate. In contrast, the stage worsened or remained at stage 5 more in patients with cardiovascular disease or diabetes mellitus. Declining CKD stage and increasing CRP were influential risk factors that affect mortality.
Conclusion: It is essential to closely monitor the changes in laboratory parameters at baseline and follow-up in CKD patients to predict or prevent comorbidities, mortality, and deterioration in patients' renal functions.
{"title":"The effects of chronic kidney disease stages on dyslipidemia, cardiovascular disease prevalence and mortality.","authors":"Emre Hoca, Huseyin Bulent Mermer, Atay Can Kula, Suleyman Ahbab, Hayriye Esra Ataoglu","doi":"10.14744/nci.2024.81582","DOIUrl":"10.14744/nci.2024.81582","url":null,"abstract":"<p><strong>Objective: </strong>Cardiovascular disease (CVD) is the most common cause of death in chronic kidney disease (CKD) patients. The prevalence of CVD is significantly increased in CKD patients, and the frequency of CVD increases as the CKD stage worsens. Although atherosclerosis is more common in CKD patients, the lipid profile may change as the CKD stage changes. Many mechanisms cause this. Also, mortality is more common in patients with advanced CKD. In this study, we aim to emphasize the incidence of cardiovascular diseases and dyslipidemia in patients with CKD at different stages and the effect of these variable conditions on patient mortality.</p><p><strong>Methods: </strong>Patients who applied to the internal medicine outpatient clinic and were diagnosed with chronic kidney disease were examined. Mortality and complications were followed up for one year. A total of 1323 patients with a diagnosis of CKD between stages 3a-5 were included in the study. The relationships between kidney functions and lipid profiles, biochemical values, and prognosis of the patients were evaluated.</p><p><strong>Results: </strong>Non-survivors had lower glomerular filtration rate (GFR) and higher C-reactive protein (CRP) levels. High-density lipoprotein (HDL), low-density lipoprotein (LDL), and albumin values decreased, and CRP increased as the disease stage progressed. More survivors had CKD and hyperlipidemia than non-survivors. It was observed that the stage remained the same in patients with hyperlipidemia at a higher rate. In contrast, the stage worsened or remained at stage 5 more in patients with cardiovascular disease or diabetes mellitus. Declining CKD stage and increasing CRP were influential risk factors that affect mortality.</p><p><strong>Conclusion: </strong>It is essential to closely monitor the changes in laboratory parameters at baseline and follow-up in CKD patients to predict or prevent comorbidities, mortality, and deterioration in patients' renal functions.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"95-102"},"PeriodicalIF":0.9,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-08eCollection Date: 2025-01-01DOI: 10.14744/nci.2023.58630
Berker Okay, Ceren Dogan Kalinbacoglu, Gulsen Akkoc, Halil Ugur Hatipoglu, Omer Dogan, Kamil Sahin, Derya Buyukkayhan
Objective: Preseptal cellulitis is an infection of the palpebrae and the periorbital superficial tissue and is more common in children than adults. This study aims to evaluate the demographic and clinical characteristics of children hospitalized for preseptal cellulitis and the factors affecting these characteristics.
Methods: In this retrospective, single-center study, 101 children hospitalized for preseptal cellulitis between March 2019 and March 2022 were included. The patients were divided into 2 groups as under five years old and over five years old.
Results: 56 patients (55.4%) were male and the median age was 56 (24-89) months. All patients had eye swelling. Periorbital erythema was seen in 81 (80.1%), conjunctivitis in 39 (38.6%), eye discharge in 30 (29.7%) patients. The most common treatment was ampicillin-sulbactam+clindamycin (77.2%). Mean treatment duration was 8.42±2.89 days, clinical improvement was 5.01±2.20 days. Patients with leukocytosis had longer duration of treatment compared to patients without leukocytosis (9.3±3.1 vs. 7.8±2.5 days, p=0.009). While the lymphocyte level was higher in patients under 5 years of age compared to patients over 5 years of age (p<0.001); neutrophil (p<0.001), hemoglobin (p=0.002) and NLR (p<0.001) levels were low. The duration of clinical improvement was short in patients under 5 years of age (4.4±1.6 vs. 5.6±2.5 days, p=0.005).
Conclusion: The most common finding in patients with preseptal cellulitis was swelling in the eye. The presence of leukocytosis in patients may be used to predict the duration of treatment. Age was an important factor in predicting the duration of clinical improvement in patients.
目的:隔膜前蜂窝织炎是一种眼睑及眶周浅表组织感染,儿童较成人多见。本研究旨在评估因隔膜前蜂窝织炎住院的儿童的人口学和临床特征以及影响这些特征的因素。方法:在这项回顾性的单中心研究中,纳入了2019年3月至2022年3月期间因隔膜前蜂窝织炎住院的101名儿童。患者分为5岁以下和5岁以上两组。结果:男性56例(55.4%),中位年龄56(24-89)个月。所有患者均有眼肿。眼眶周围红斑81例(80.1%),结膜炎39例(38.6%),眼部分泌物30例(29.7%)。最常见的治疗是氨苄青霉素-舒巴坦+克林霉素(77.2%)。平均治疗时间为8.42±2.89 d,临床改善时间为5.01±2.20 d。有白细胞增多症的患者比无白细胞增多症的患者治疗时间更长(9.3±3.1 vs. 7.8±2.5天,p=0.009)。而5岁以下患者的淋巴细胞水平高于5岁以上患者(p结论:隔膜前蜂窝织炎患者最常见的表现是眼睛肿胀。患者白细胞增多的存在可以用来预测治疗的持续时间。年龄是预测患者临床改善持续时间的重要因素。
{"title":"Evaluating hospitalized children for preseptal cellulitis: A single-center experience and current literature review.","authors":"Berker Okay, Ceren Dogan Kalinbacoglu, Gulsen Akkoc, Halil Ugur Hatipoglu, Omer Dogan, Kamil Sahin, Derya Buyukkayhan","doi":"10.14744/nci.2023.58630","DOIUrl":"10.14744/nci.2023.58630","url":null,"abstract":"<p><strong>Objective: </strong>Preseptal cellulitis is an infection of the palpebrae and the periorbital superficial tissue and is more common in children than adults. This study aims to evaluate the demographic and clinical characteristics of children hospitalized for preseptal cellulitis and the factors affecting these characteristics.</p><p><strong>Methods: </strong>In this retrospective, single-center study, 101 children hospitalized for preseptal cellulitis between March 2019 and March 2022 were included. The patients were divided into 2 groups as under five years old and over five years old.</p><p><strong>Results: </strong>56 patients (55.4%) were male and the median age was 56 (24-89) months. All patients had eye swelling. Periorbital erythema was seen in 81 (80.1%), conjunctivitis in 39 (38.6%), eye discharge in 30 (29.7%) patients. The most common treatment was ampicillin-sulbactam+clindamycin (77.2%). Mean treatment duration was 8.42±2.89 days, clinical improvement was 5.01±2.20 days. Patients with leukocytosis had longer duration of treatment compared to patients without leukocytosis (9.3±3.1 vs. 7.8±2.5 days, p=0.009). While the lymphocyte level was higher in patients under 5 years of age compared to patients over 5 years of age (p<0.001); neutrophil (p<0.001), hemoglobin (p=0.002) and NLR (p<0.001) levels were low. The duration of clinical improvement was short in patients under 5 years of age (4.4±1.6 vs. 5.6±2.5 days, p=0.005).</p><p><strong>Conclusion: </strong>The most common finding in patients with preseptal cellulitis was swelling in the eye. The presence of leukocytosis in patients may be used to predict the duration of treatment. Age was an important factor in predicting the duration of clinical improvement in patients.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"89-94"},"PeriodicalIF":0.9,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364465/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144984937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-06eCollection Date: 2025-01-01DOI: 10.14744/nci.2024.88785
Tugba Buzluk, Eltaf Torun, Behcet Al, Turab Sami Altay, Melik Gazi Buzluk
Objective: Many patients visit the emergency department with headaches. The most crucial point in patient management is detecting secondary headaches. Accurate history, detailed physical examination, and appropriate neuroimaging are essential for diagnosis. This study aimed to examine the compatibility of neuroimaging findings with the symptoms of patients presenting to the emergency department with non-traumatic headaches.
Methods: The data regarding the reasons for application, demographic information, accompanying symptoms, and neuroimaging results of patients who visited the green area of Goztepe Prof. Dr. Suleyman Yalcin City Hospital Emergency Medicine Clinic with headache complaints from June 2022 to June 2023 were analyzed.
Results: The study included 4,908 individuals, with 38.33% identifying as male and 61.67% as female. The mean age was 42.34±19.13 years. Additionally, 75.28% of participants experienced issues beyond headaches, while 78.71% had no prior medical diagnoses. High blood pressure was the most reported condition, affecting 6.66% of those studied. Among the patients, 23.68% were advised to undergo a non-contrast CT scan, and 96.78% did not require further imaging. Thirty-two individuals (0.65%) were found to have underlying conditions that could lead to secondary headaches. Among these, 27 cases (84.37%) showed no additional symptoms (p=0.0001). A total of 99.61% of individuals were discharged from the emergency room. The age distribution did not correlate with the identified pathologies responsible for secondary headaches (p=0.058).
Conclusion: Our neuroimaging rates exceeded those found in the literature. Women were more likely to visit the emergency department for headaches. Three out of five patients experienced additional symptoms, predominantly hypertension. Approximately four out of five patients had no previous diagnosis. CT scanning was considered the gold standard for diagnosis. The occurrence of secondary headaches and associated symptoms was low. There was no correlation between increasing age and secondary headaches.
{"title":"Analysis of brain scan findings requested from individuals visiting the emergency department outpatient clinic with headache.","authors":"Tugba Buzluk, Eltaf Torun, Behcet Al, Turab Sami Altay, Melik Gazi Buzluk","doi":"10.14744/nci.2024.88785","DOIUrl":"10.14744/nci.2024.88785","url":null,"abstract":"<p><strong>Objective: </strong>Many patients visit the emergency department with headaches. The most crucial point in patient management is detecting secondary headaches. Accurate history, detailed physical examination, and appropriate neuroimaging are essential for diagnosis. This study aimed to examine the compatibility of neuroimaging findings with the symptoms of patients presenting to the emergency department with non-traumatic headaches.</p><p><strong>Methods: </strong>The data regarding the reasons for application, demographic information, accompanying symptoms, and neuroimaging results of patients who visited the green area of Goztepe Prof. Dr. Suleyman Yalcin City Hospital Emergency Medicine Clinic with headache complaints from June 2022 to June 2023 were analyzed.</p><p><strong>Results: </strong>The study included 4,908 individuals, with 38.33% identifying as male and 61.67% as female. The mean age was 42.34±19.13 years. Additionally, 75.28% of participants experienced issues beyond headaches, while 78.71% had no prior medical diagnoses. High blood pressure was the most reported condition, affecting 6.66% of those studied. Among the patients, 23.68% were advised to undergo a non-contrast CT scan, and 96.78% did not require further imaging. Thirty-two individuals (0.65%) were found to have underlying conditions that could lead to secondary headaches. Among these, 27 cases (84.37%) showed no additional symptoms (p=0.0001). A total of 99.61% of individuals were discharged from the emergency room. The age distribution did not correlate with the identified pathologies responsible for secondary headaches (p=0.058).</p><p><strong>Conclusion: </strong>Our neuroimaging rates exceeded those found in the literature. Women were more likely to visit the emergency department for headaches. Three out of five patients experienced additional symptoms, predominantly hypertension. Approximately four out of five patients had no previous diagnosis. CT scanning was considered the gold standard for diagnosis. The occurrence of secondary headaches and associated symptoms was low. There was no correlation between increasing age and secondary headaches.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"129-137"},"PeriodicalIF":0.9,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: Screening for latent tuberculosis (LTB) is necessary, especially for people living with human immunodeficiency virus (HIV) and people receiving anti-TNF therapy. Although there is no microbiological test accepted as the gold standard, interferon-gamma release assays (IGRAs) are suggested to be used by World Health Organization. We aimed to analyze QuantiFERON®-TB Gold Plus test results in different patient groups with high reactivation risk.
Methods: Patients admitted to Marmara University Pendik Training and Research Hospital Microbiology Laboratory between August 2016 - March 2020 have been analyzed retrospectively. Patient demographic data was obtained from the records of the laboratory information management system. Blood samples have been studied as recommended by the manufacturer (QuantiFERON®-TB Gold Plus, QIAGEN, Germany).
Results: We evaluated samples from 1506 patients, of whom with a chronic inflammatory disease (CID) in 1223 patients and HIV positivity among 283 patients. Mean age was 38.29±12.66 for HIV patients and 41.57±14.45 for chronic inflammatory disease patients. QFT test was positive in 319 (21.2%) of 1506 patients in total and in 43 (15.2%) of HIV patients and in 276 (22.6%) of CID patients. Indeterminate results were obtained in 1.7% (n=26) of the samples. Among patients with CID highest rate of QFT test positivity was detected among patients with psoriasis (27.8%), followed by patients with rheumatoid arthritis (21.8%) and ankylosing spondylitis (19.8%). Active tuberculosis was not developed in any of QFT-GIT-positive CID patients followed up in our hospital for the 4 years period.
Conclusion: QuantiFERON®-TB Gold Plus test requires a short-term and one-time contact with the patient and it seems to be a suitable option for screening of patients who have a high risk of tuberculosis.
{"title":"Analysis of QuantiFERON<sup>®</sup>-TB Gold Plus test results among patients with chronic inflammatory diseases and HIV patients.","authors":"Elvan Sayin, Gamze Alci, Aslihan Ozanat, Nurcan Duman, Aysegul Karahasan","doi":"10.14744/nci.2023.88886","DOIUrl":"10.14744/nci.2023.88886","url":null,"abstract":"<p><strong>Objective: </strong>Screening for latent tuberculosis (LTB) is necessary, especially for people living with human immunodeficiency virus (HIV) and people receiving anti-TNF therapy. Although there is no microbiological test accepted as the gold standard, interferon-gamma release assays (IGRAs) are suggested to be used by World Health Organization. We aimed to analyze QuantiFERON<sup>®</sup>-TB Gold Plus test results in different patient groups with high reactivation risk.</p><p><strong>Methods: </strong>Patients admitted to Marmara University Pendik Training and Research Hospital Microbiology Laboratory between August 2016 - March 2020 have been analyzed retrospectively. Patient demographic data was obtained from the records of the laboratory information management system. Blood samples have been studied as recommended by the manufacturer (QuantiFERON<sup>®</sup>-TB Gold Plus, QIAGEN, Germany).</p><p><strong>Results: </strong>We evaluated samples from 1506 patients, of whom with a chronic inflammatory disease (CID) in 1223 patients and HIV positivity among 283 patients. Mean age was 38.29±12.66 for HIV patients and 41.57±14.45 for chronic inflammatory disease patients. QFT test was positive in 319 (21.2%) of 1506 patients in total and in 43 (15.2%) of HIV patients and in 276 (22.6%) of CID patients. Indeterminate results were obtained in 1.7% (n=26) of the samples. Among patients with CID highest rate of QFT test positivity was detected among patients with psoriasis (27.8%), followed by patients with rheumatoid arthritis (21.8%) and ankylosing spondylitis (19.8%). Active tuberculosis was not developed in any of QFT-GIT-positive CID patients followed up in our hospital for the 4 years period.</p><p><strong>Conclusion: </strong>QuantiFERON<sup>®</sup>-TB Gold Plus test requires a short-term and one-time contact with the patient and it seems to be a suitable option for screening of patients who have a high risk of tuberculosis.</p>","PeriodicalId":94347,"journal":{"name":"Northern clinics of Istanbul","volume":"12 1","pages":"29-35"},"PeriodicalIF":0.9,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12364469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144985016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}